Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series

Vaccine

Volumn 34, Issue 31, 2016, Pages 3598-3606

  Dos Santos, Gaël ^a   Haguinet, François ^a   Cohet, Catherine ^a   Webb, Dave ^b   Logie, John ^b   Ferreira, Germano L C ^a,c   Rosillon, Dominique ^a   Shinde, Vivek ^a,d  

^a GSK   (Belgium)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Stockley Park West ^*  (Belgium)

^d NOVAVAX INC   (United States)

Author keywords

Influenza; Pharmacoepidemiology; Safety; Self controlled case series; Transplant rejection; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; DATA BASE; ENGLAND; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; INFLUENZA VACCINATION; KIDNEY GRAFT REJECTION; LIVER GRAFT REJECTION; LUNG GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEASONAL INFLUENZA; SEASONAL VARIATION; INFANT; INFLUENZA, HUMAN; POSTMARKETING SURVEILLANCE; PRESCHOOL CHILD; RISK ASSESSMENT; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; GRAFT REJECTION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRANSPLANT RECIPIENTS; VACCINATION; YOUNG ADULT;

EID: 84969931846     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.05.016     Document Type: Article

References (30)

1. Kumar D., Blumberg E.A., Danziger-Isakov L., Kotton C.N., Halasa N.B., Ison M.G., et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant 2011, 11:2020-2030.
2. Cordero E., Manuel O. Influenza vaccination in solid-organ transplant recipients. Curr Opin Organ Transpl 2012, 17:601-608.
3. Kumar D., Michaels M.G., Morris M.I., Green M., Avery R.K., Liu C., et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010, 10:521-526.
4. Cordero E., Perez-Romero P., Moreno A., Len O., Montejo M., Vidal E., et al. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clin Microbiol Infect 2012, 18:67-73.
5. Keane W.R., Helderman J.H., Luby J., Gailiunas P., Hull A.R., Kokko J.P. Epidemic renal transplant rejection associated with influenza A Victoria. Proc Clin Dial Transpl Forum 1978, 8:232-236.
6. Billings J.L., Hertz M.I., Savik K., Wendt C.H. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transpl 2002, 21:559-566.
7. Garantziotis S., Howell D.N., McAdams H.P., Davis R.D., Henshaw N.G., Palmer S.M. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest 2001, 119:1277-1280.
8. Public Health England Chapter 19: influenza 2015, [accessed 17.02.16]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/456568/2904394_Green_Book_Chapter_19_v10_0.pdf.
9. Avery R.K. Influenza vaccines in the setting of solid-organ transplantation: are they safe. Curr Opin Infect Dis 2012, 25:464-468.
10. Vistoli F., Focosi D., De Donno M., Giannecchini S., Mariotti M.L., Occhipinti M., et al. Pancreas rejection after pandemic influenzavirus A(H1N1) vaccination or infection: a report of two cases. Transpl Int 2011, 24:e28-e29.
11. Schaffer S.A., Husain S., Delgado D.H., Kavanaugh L., Ross H.J. Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transpl 2011, 11:2751-2754.
12. Katerinis I., Hadaya K., Duquesnoy R., Ferrari-Lacraz S., Meier S., van Delden C., et al. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transpl 2011, 11:1727-1733.
13. Cohet C., Haguinet F., Dos Santos G., Webb D., Logie J., Ferreira G.L.C., et al. Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series. BMJ Open 2016, 6:e009264.
14. Farrington C.P., Whitaker H.J., Hocine M.N. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009, 10:3-16.
15. Clinical Practice Research Datalink Welcome to the Clinical Practice Research Datalink 2016, [accessed 17.02.16]. https://www.cprd.com/home/.
16. Herrett E., Gallagher A.M., Bhaskaran K., Forbes H., Mathur R., van Staa T., et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015, 44:827-836.
17. Clinical Practice Research Datalink Coded data 2015, [accessed 17.02.16]. http://www.cprd.com/ObservationalData/CodedData.asp?zoom_highlight=hospital+episodes.
18. Williams T., van Staa T., Puri S., Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012, 3:89-99.
19. Health and Social Care Information Centre Hospital Episodes Statistics 2015, [accessed 17.02.16]. http://www.hscic.gov.uk/hes.
20. Sinha S., Peach G., Poloniecki J.D., Thompson M.M., Holt P.J. Studies using English administrative data (Hospital Episode Statistics) to assess health-care outcomes - systematic review and recommendations for reporting. Eur J Public Health 2013, 23:86-92.
21. World Health Organization WHO recommendations on the composition of influenza virus vaccines 2015, [accessed 17.02.16]. http://www.who.int/influenza/vaccines/virus/recommendations/en/.
22. Farrington C.P., Hocine M.N. Within-individual dependence in self-controlled case series models for recurrent events. J R Stat Soc Ser C Appl Stat 2010, 59:457-475.
23. Farrington C.P. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995, 51:228-235.
24. Whitaker H.J., Farrington C.P., Spiessens B., Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006, 25:1768-1797.
25. Engels E.A., Pfeiffer R.M., Fraumeni J.F., Kasiske B.L., Israni A.K., Snyder J.J., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011, 306:1891-1901.
26. Zbinden D., Manuel O. Influenza vaccination in immunocompromised patients: efficacy and safety. Immunotherapy 2014, 6:131-139.
27. Manuel O., Lopez-Medrano F., Keiser L., Welte T., Carratala J., Cordero E., et al. Influenza and other respiratory virus infections in solid organ transplant recipients. Clin Microbiol Infect 2014, 20(Suppl. 7):102-108.
28. Siegrist C.A., Ambrosioni J., Bel M., Combescure C., Hadaya K., Martin P.Y., et al. Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther 2012, 17:893-903.
29. Herrett E., Thomas S.L., Schoonen W.M., Smeeth L., Hall A.J. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010, 69:4-14.
30. Dos Santos G., Neumeier E., Bekkat-Berkani R. Influenza - can we cope better with the unpredictable?. Hum Vaccin Immunother 2015, [Epub ahead of print].